Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes

Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Pharmacological Research - Volume 107, May 2016, Pages 125-136

Marika Massaro, Egeria Scoditti, Mariangela Pellegrino, Maria Annunziata Carluccio, Nadia Calabriso, Martin Wabitsch, Carlo Storelli, Matthew Wright, Raffaele De Caterina,